(Q37728073)

22 August 2017

1 reference

title

Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay (English)

1 reference

22 August 2017

0 references

Kevin Niswender

1

1 reference

22 August 2017

publication date

1 April 2010

1 reference

Diabetes, Obesity and Metabolism

22 August 2017

published in

1 reference

22 August 2017

volume

12

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

267-287

1 reference

Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Weight Change and Diabetes Incidence: Findings from a National Cohort of US Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Initiation of therapy for patients with essential hypertension or comorbid conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Insulin Secretion in Obesity and Diabetes: An Illustrative Case

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

The management of the obese diabetic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Meta-analysis: the effect of dietary counseling for weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Anemia following Roux-en-Y surgery for morbid obesity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Diet Therapy of Diabetes: An Analysis of Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Diabetes, TZDs, and Bone: A Review of the Clinical Evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Insulin resistance and the effect of insulin on blood pressure in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Metabolic effects of isradipine versus hydrochlorothiazide in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Effect of diuretics on the plasma lipid profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Mechanisms of diuretic effects on carbohydrate tolerance, insulin sensitivity and lipid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2009.01175.X

10.1111/J.1463-1326.2009.01175.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference